Virtual Conference

Track: Cardiovascular Impact of COVID-19

Cardiovascular Impact of COVID-19


As we all are aware of the infection COVID -19 which is spread all over the world caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Even though, it primarily affects the respiratory system, it can also cause cardiovascular complications. Patients with pre-existing cardiovascular problems are at major risk for severity of illness and mortality. According to the survey and case reports, we understand that more than 40% of the Covid -19 patients are affected by cardiovascular diseases. Fatality rates for comorbid patients are more than the average population.

      - Cancer: 5.6%
      - Hypertension: 6%
      - Diabetes: 7.3%
      - Cardiovascular disease: 10.5%

Related Societies: Cardiology Society Los Angeles, USA, North America; Japanese Circulation Society, Japan;  World Society of Arrhythmias Beijing, China; Philippine Heart Association Manila, Philippines; American Heart Association Dallas, USA; Asian Society for Cardiovascular Surgery (ASCVS) Fukuoka, Japan; The Pan-African Society of Cardiology (PASCAR) Algeria, Africa; Cardiac Society of Australia and New Zealand Sydney, Australia; British Junior Cardiologists Association, UK.